Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

MannKind Corporation - Common Stock (NQ:MNKD)

4.240 +0.170 (+4.18%)
Streaming Delayed Price Updated: 12:12 PM EDT, Aug 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
7 Biotech Stocks to Sell in July ↗
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July. 
Via InvestorPlace
News headline image
MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)
From MannKind
Via GlobeNewswire
News headline image
7 Overvalued Penny Stocks to Sell Before June 2023 ↗
It's time to make your exit from these overvalued penny stocks to sell, as their respective valuations are unsustainable. 
Via InvestorPlace
News headline image
Dr. Burkhard Blank Joins MannKind as Executive Vice President of Research & Development and Chief Medical Officer
From MannKind
Via GlobeNewswire
News headline image
Why Shares of MannKind Are Up Wednesday ↗
The company released its first-quarter earnings report on Tuesday. 
Via The Motley Fool
News headline image
MannKind (MNKD) Q1 2023 Earnings Call Transcript ↗
MNKD earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
MannKind: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Avoid Like the Plague ↗
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace
News headline image
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
News headline image
Looking Into MannKind's Return On Capital Employed ↗
 
Via Benzinga
News headline image
MannKind (MNKD) Q4 2022 Earnings Call Transcript ↗
MNKD earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
MannKind Earnings Preview ↗
 
Via Benzinga
News headline image
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
MannKind Corporation to Participate in the 2023 RBC Capital Markets Global Healthcare Conference
From MannKind
Via GlobeNewswire
News headline image
CORRECTION -- MannKind Corporation Reports 2023 First Quarter Financial Results
Conference Call to Begin Today at 5:00 p.m. (ET) 
From MannKind
Via GlobeNewswire
News headline image
Mannkind Corporation Reports 2023 First Quarter Financial Results
Conference Call to Begin Today at 5:00 p.m. (ET) 
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation to Hold 2023 First Quarter Financial Results Conference Call on May 9, 2023
From MannKind
Via GlobeNewswire
News headline image
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market ↗
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at... 
Via Talk Markets
News headline image
Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer
From MannKind
Via GlobeNewswire
News headline image
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market... 
Via Benzinga
News headline image
MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference
From MannKind
Via GlobeNewswire
News headline image
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday ↗
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to... 
Via Benzinga
News headline image
Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
Conference Call to Begin Today at 5:00 p.m. (ET) 
From MannKind
Via GlobeNewswire
News headline image
Earnings Scheduled For February 23, 2023 ↗
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
From MannKind
Via GlobeNewswire
News headline image
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
From MannKind
Via GlobeNewswire
News headline image
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
From MannKind
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.